Friday, October 16, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 20, 2026

Crypto News: Pepeto Crosses $10.13 Million While Bitcoin Price Prediction Targets $150,000 as Senate Votes to End Trump's Iran War

View original at globenewswire.com
“Over $10.13 million raised, stages closing in days, and addresses tied to large Bitcoin holders entering at a speed that says everything.”
Verbatim excerpt from the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Every trade on PepetoSwap generates buying pressure on the Pepeto token, the same model that lifted BNB from pennies to $1,369

    60% confidence
  • Pepeto is the first presale to combine a zero-fee exchange, AI contract review, and staking returns as high as 172% APY

    60% confidence
  • Senate passed a war powers resolution 50-47 on May 19 with four Republicans joining Democrats to limit Trump's military operations in Iran

    60% confidence
  • Xi Jinping offered to help end the Iran conflict at the China summit

    60% confidence
  • Bitcoin price prediction for 2026 sits at $150,000

    60% confidence
  • Pepeto was built by the cofounder of the Pepe ecosystem, who created a $7 billion token, alongside a developer from Binance

    60% confidence
  • Crypto fund inflows hit $858 million last week, with Bitcoin products pulling $706 million and the largest weekly unwind of short positions in 2026

    60% confidence
  • On May 19, a tracked whale with $24.79 million in verified profits opened $21 million in longs across BTC, ETH, and DOGE

    60% confidence
  • Bitcoin could reach $200,000 if Iran tensions end

    60% confidence
  • Bitcoin trades at $77,070 on May 20, 2026

    60% confidence

Data points we hold from this source

Pepeto · cash10.13 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com
Crypto News: Pepeto Crosses $10.13 Million While Bitcoin Price Prediction Targets $150,000 as Senate Votes to End Trump's Iran War — Source | Via News | Finance Via News